Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Mark A Socinski

Showing results (71-80 of 279) with videos related to

Pageof 28
Sort By:
Clinical Lung Cancer|December 24, 2013
Assessing response to treatment in non--small-cell lung cancer: role of tumor volume evaluated by computed tomographyFriedrich D Knollmann, Rohan Kumthekar, David Fetzer, et al.
Biometrics|March 10, 2011
Reinforcement learning strategies for clinical trials in nonsmall cell lung cancerYufan Zhao, Donglin Zeng, Mark A Socinski, et al.
Cancer Journal (Sudbury, Mass.)|May 28, 2013
Management of normal tissue toxicity associated with chemoradiation (primary skin, esophagus, and lung)Victor Y Yazbeck, Liza Villaruz, Marsha Haley, et al.
Lung Cancer (Amsterdam, Netherlands)|November 7, 2006
Women and lung cancer: epidemiology, tumor biology, and emerging trends in clinical researchChandra P Belani, Sherry Marts, Joan Schiller, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|March 10, 2010
If histology mattersThomas E Stinchcombe, Juneko E Grilley-Olson, Mark A Socinski
Translational Lung Cancer Research|March 26, 2015
Immunotherapy in lung cancerLiza C Villaruz, Aparna Kalyan, Hassane Zarour, et al.
Experimental Hematology & Oncology|December 18, 2015
Near complete response after single dose of nivolumab in patient with advanced heavily pre-treated KRAS mutant pulmonary adenocarcinomaDiwakar Davar, Mark A Socinski, Sanja Dacic, et al.
Clinical Advances in Hematology & Oncology : H&O|July 6, 2016
HSP90 inhibitors in lung cancer: promise still unfulfilledSuman Chatterjee, Saveri Bhattacharya, Mark A Socinski, et al.
Cancer|August 12, 2003
Measuring the side effects of taxane therapy in oncology: the functional assesment of cancer therapy-taxane (FACT-taxane)David Cella, Amy Peterman, Stacie Hudgens, et al.
Chest|January 16, 2003
Chemotherapeutic management of stage IV non-small cell lung cancerMark A Socinski, David E Morris, Gregory A Masters, et al.
Pageof 28

Showing results (71-80 of 279) with videos related to

Sort By:
Pageof 28
Clinical Lung Cancer|December 24, 2013
Assessing response to treatment in non--small-cell lung cancer: role of tumor volume evaluated by computed tomographyFriedrich D Knollmann, Rohan Kumthekar, David Fetzer, et al.
Biometrics|March 10, 2011
Reinforcement learning strategies for clinical trials in nonsmall cell lung cancerYufan Zhao, Donglin Zeng, Mark A Socinski, et al.
Cancer Journal (Sudbury, Mass.)|May 28, 2013
Management of normal tissue toxicity associated with chemoradiation (primary skin, esophagus, and lung)Victor Y Yazbeck, Liza Villaruz, Marsha Haley, et al.
Lung Cancer (Amsterdam, Netherlands)|November 7, 2006
Women and lung cancer: epidemiology, tumor biology, and emerging trends in clinical researchChandra P Belani, Sherry Marts, Joan Schiller, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|March 10, 2010
If histology mattersThomas E Stinchcombe, Juneko E Grilley-Olson, Mark A Socinski
Translational Lung Cancer Research|March 26, 2015
Immunotherapy in lung cancerLiza C Villaruz, Aparna Kalyan, Hassane Zarour, et al.
Experimental Hematology & Oncology|December 18, 2015
Near complete response after single dose of nivolumab in patient with advanced heavily pre-treated KRAS mutant pulmonary adenocarcinomaDiwakar Davar, Mark A Socinski, Sanja Dacic, et al.
Clinical Advances in Hematology & Oncology : H&O|July 6, 2016
HSP90 inhibitors in lung cancer: promise still unfulfilledSuman Chatterjee, Saveri Bhattacharya, Mark A Socinski, et al.
Cancer|August 12, 2003
Measuring the side effects of taxane therapy in oncology: the functional assesment of cancer therapy-taxane (FACT-taxane)David Cella, Amy Peterman, Stacie Hudgens, et al.
Chest|January 16, 2003
Chemotherapeutic management of stage IV non-small cell lung cancerMark A Socinski, David E Morris, Gregory A Masters, et al.
Pageof 28